References
- Afatinib-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB08916 [accessed 2017 June 26].
- Allsopp P, Possemiers S, Campbell D, Gill C, Rowland I. 2013. A comparison of the anticancer properties of isoxanthohumol and 8-prenylnaringenin using in vitro models of colon cancer. Biofactors. 39:441–447.
- Aso Y, Yoshioka S, Takeda Y. 1990. Epimerization and racemization of some chiral drugs in the presence of human serum albumin. Chem Pharm Bull. 38:180–184.
- Aminopterin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB08878 [accessed 2017 June 26].
- Ariens EJ. 1984. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol. 26:663–668.
- Barski OA, Tipparaju SM, Bhatnagar A. 2008. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev. 40:553–624.
- Cahn RS, Ingold C, Prelog V. 1966. Specification of molecular chirality. Angew Chem Int Ed. 5:385–415.
- Campo VL, Bernardes LS, Carvalho I. 2009. Stereoselectivity in drug metabolism: molecular mechanisms and analytical methods. Curr Drug Metab. 10:188–205.
- Chen CS, Jounaidi Y, Waxman DJ. 2005. Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450. Drug Metab Dispos. 33:1261–1267.
- Choong E, Dobrinas M, Carrupt PA, Eap CB. 2010. The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution. Expert Opin Drug Metab Toxicol. 6:953–965.
- Crizotinib-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB08865 [accessed 2017 June 26].
- Cyclophosphamide-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00531 [accessed 2017 June 26].
- Damle BD, Narasimhan NI, Kaul S. 2001. Stereoselective metabolism and pharmacokinetics of tegafur. Biopharm Biopharm Drug Dispos. 22:45–52.
- Daunorubicin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00694 [accessed 2017 June 26].
- Decitabine-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB01262 [accessed 2017 June 26].
- Doxorubicin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00997 [accessed 2017 June 26].
- Epirubicin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00445 [accessed 2017 June 26].
- Eribulin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB08871 [accessed 2017 June 26].
- Etoposide-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00773 [accessed 2017 June 26].
- Fan HR, Zhang WG. 2005. Stereoselective metabolism and pharmacokinetics of chiral drugs. Eur J Drug Metab Ph. 5:169–178.
- Fabro S, Smith RL, Williams RT. 1967. Toxicity and teratogenicity of optical isomers of thalidomide. Nature. 215:296–297.
- Food-and-Drug-Administration (US FDA). 2014. Guidance (drugs): development of new stereoisomeric drugs [online]. Available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm122883.htm [last accessed 28 September 2017].
- Gemcitabine-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00441 [accessed 2017 June 26].
- Gu Y, Wang G-J, Wu X-L, Zheng Y-T, Zhang J-W, Ai H, Sun J-G, Jia Y-W. 2010. Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters. Xenobiotica. 40:602–612.
- Guo J, Nikolic D, Chadwick LR, Pauli GF, van Breemen RB. 2006. Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humuluslupulus L.). Drug Metab Dispos. 34:1152–1159.
- He Y, Liu Y, Zeng S. 2010. Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction. Chirality. 22:684–692.
- Ifosfamide-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB01181 [accessed 2017 June 26].
- Irinotecan-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00762 [accessed 2017 June 26].
- Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H. 2010. Identification of a primary target of thalidomide teratogenicity. Science. 327:1345–1350.
- Jaffe N, Gorlick R. 2008. High-dose methotrexate in osteosarcoma: let the questions surcease-time for final acceptance. J Clin Oncol. 26:4365–4366.
- Karlsson L, Carlsson B, Hiemke C, Ahlner J, Bengtsson F, Schmitt U, Kugelberg FC. 2013. Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment. Eur Neuropsychopharmacol. 23:1636–1644.
- Kim H, Likhari P, Lin CC, Nomeir AA. 1999. High-performance liquid chromatographic analysis of the anti-tumor agent SCH 66336 in cynomolgus monkey plasma and evaluation of its chiral inversion in animals. J Chromatogr B. 728:133–141.
- Kobunai T, Saito H, Takechi T. 2016. Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and EGFR inhibitor. US Patent 9345767; 24 May.
- Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, et al. 2014. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42:1091–1097.
- Lin G-Q, You Q-D, Cheng J-F. 2011. Chiral drugs: chemistry and biological action. Hoboken (NJ): Wiley & Sons.
- Lu H, Wang JJ, Chan KK, Philip PA. 2006. Stereoselectivity in metabolism of ifosfamide by CYP3A4 and CYP2B6. Xenobiotica. 36:367–385.
- Lu H, Wang JJ, Chan KK. 2006. Enantiomer-enantiomer interaction of ifosfamide in the rat. Xenobiotica. 36:535–549.
- Lu H. 2007. Stereoselectivity in drug metabolism. Expert Opin Drug Metab Toxicol. 3:149–158.
- Malátková P, Wsól V. 2014. Carbonyl reduction pathways in drug metabolism. Drug Metab Rev. 46:96–123.
- Melphalan-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB01042 [accessed 2017 June 26].
- Menter A, Thrash B, Cherian C, Matherly LH, Wang L, Gangjee A, Morgan JR, Maeda DY, Schuler AD, Kahn SJ, et al. 2012. Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporter. J Pharmacol Exp Ther. 342:696–708.
- Methotrexate-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00563 [accessed 2017 June 26].
- Mordente A, Meucci E, Martorana GE, Giardina B, Minotti G. 2001. Human heart cytosolic reductases and anthracycline cardiotoxicity. IUBMB Life. 52:83–88.
- Mordente A, Minotti G, Martorana GE, Silvestrini A, Giardina B, Meucci E. 2003. Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications. Biochem Pharmacol. 66:989–998.
- Mordente A, Meucci E, Martorana GE, Tavian D, Silvestrini A. 2017. Topoisomerases and anthracyclines: recent advances and perspectives in anticancer therapy and prevention of cardiotoxicity. Curr Med Chem. 24:1607–1626.
- Morgillo F, Lee HY. 2006. Lonafarnib in cancer therapy. Expert Opin Investig Drugs. 15:709–719.
- Narawa T, Itoh T. 2010. Stereoselective transport of amethopterin enantiomers by the proton-coupled folate transporter. Drug Metab Pharmacokinet. 25:283–289.
- Noey EL, Tibrewal N, Jiménez-Osés G, Osuna S, Park J, Bond CM, Cascio D, Liang J, Zhang X, Huisman GW, et al. 2015. Origins of stereoselectivity in evolved ketoreductases. Proc Natl Acad Sci USA. 112:E7065–E7072.
- Nikolic D, Li Y, Chadwick LR, Pauli GF, van Breemen RB. 2005. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J Mass Spectrom. 40:289–299.
- Oxaliplatin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00526 [accessed 2017 June 26].
- Giraud B, Hebert G, Deroussent A, Veal GJ, Vassal G, Paci A. 2010. Oxazaphosphorines: new therapeutic strategies for an old class of drugs. Expert Opin Drug Metab Toxicol. 6:919–938.
- Pham Y-T, Régina A, Farinotti R, Couraud P-O, Wainer IW, Roux F, Gimenez F. 2000. Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochim Biophys Acta. 1524:212–219.
- Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F. 2006. Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. J Med Chem. 49:923–931.
- Romidepsin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB06176 [accessed 26 June 2017].
- Roy P, Tretyakov O, Wright J, Waxman DJ. 1999. Stereoselective metabolism of ifosfamide by human P-450s 3A4 and 2B6. Favorable metabolic properties of R-enantiomer. Drug Metab Dispos. 27:1309–1318.
- Savino S, Ferrandi EE, Forneris F, Rovida S, Riva S, Monti D, Mattevi A. 2016. Structural and biochemical insights into 7β-hydroxysteroid dehydrogenase stereoselectivity. Proteins. 84:859–865.
- Schmid MG, Gübitz G. 2011. Enantioseparation by chromatographic and electromigration techniques using ligand-exchange as chiral separation principle. Anal Bioanal Chem. 400:2305–2316.
- Shah RR. 2003. Improving clinical risk/benefit through stereochemistry. In: Eichelbaum M, Testa B, Somogyi A, editor. Stereochemical aspects of drug action and disposition. Berlin: SpringerVerlag; p. 401–432.
- Shen S, He Y, Zeng S. 2007. Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers. Chirality. 19:485–490.
- Singh J, Hagen TJ. 2010. Discovering lead molecules. In: Abraham DJ, Rotella DP, editor. Burger’s medicinal chemistry, drug discovery, and development. Vol. 2, 7th ed. Hoboken (NJ): Wiley & Sons; p. 127–166.
- Sirolimus-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00877 [accessed 2017 June 26].
- Skálová L, Nobilis M, Szotáková B, Kondrová E, Savlík M, Wsól V, Pichard-Garcia L, Maser E. 2002. Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro. Biochem Pharmacol. 64:297–305.
- Tegafur-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB09256 [accessed 2017 June 26].
- Testa B, Vistoli G, Pedretti A, Caldwell J. 2013. Organic stereochemistry. Part 5. Stereoselectivity in molecular and clinical pharmacology. Helv Chim Acta. 96:747–798.
- Testa B. 2013a. Organic stereochemistry. Part 7. The concept of substrate stereoselectivity in biochemistry and xenobiotic metabolism. Helv Chim Acta. 96:1203–1234.
- Testa B. 2013b. Organic stereochemistry. Part 8. Prostereoisomerism and the concept of product stereoselectivity in biochemistry andxenobiotic metabolism. Helv Chim Acta. 96:1409–1451.
- Testa B, Caldwell J, Kisakürek MV. 2014. Organic stereochemistry: guiding principles and biomedicinal relevance. Weinheim: Wiley-VCH.
- Testa B. 2015. Types of stereoselectivity in drug metabolism: a heuristic approach. Drug Metab Rev. 47:239–251.
- Topotecan-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB01030 [accessed 2017 June 26].
- Trabectedin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB05109 [last accessed last 26 June 2017].
- Vinblastine-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00570 [accessed 2017 June 26].
- Warfarin-DrugBank. 2017. [online]. Available from: https://www.drugbank.ca/drugs/DB00682 [accessed 2017 Aug 8].
- Williams PA, Cosme J, Ward A, Angove HC, Matak Vinković D, Jhoti H. 2003. Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature. 424:464–468.
- Wong NS, Morse MA. 2012. Lonafarnib for cancer and progeria. Expert Opin Investig Drugs. 21:1043–1055.
- Wsól V, Skálová L, Szotáková B. 2004. Chiral inversion of drugs: coincidence or principle?. Curr Drug Metab. 5:517–533.
- Wsól V, Szotakova B, Martin H-J, Maser E. 2007. Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man. Toxicology. 238:111–118.
- Wu C-C, Li T-K, Farh L, Lin L-Y, Lin T-S, Yu Y-J, Yen T-J, Chiang C-W, Chan N-L. 2011. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science. 333:459–462.
- Xia Q-H, Hu W, Li C, Wu J-F, Yang L, Han X-M, Shen Y-M, Li Z-Y, Li X. 2016. Design, synthesis, biological evaluation and molecular docking study on peptidomimetic analogues of XK469. Eur J Med Chem. 124:311–325.
- Yong WP, Kim TW, Undevia SD, Innocenti F, Ratain MJ. 2009. R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9. Eur J Cancer. 45:1904–1908.
- Zebala JA, Mundell A, Messinger L, Griffin CE, Schuler AD, Kahn SJ. 2014. LD-aminopterin in the canine homologue of human atopic dermatitis: A randomized, controlled trial reveals dosing factors affecting optimal therapy. PLoS One. 9:e108303.
- Zhang J, Zhou F, Niu F, Lu M, Wu X, Sun J, Wang G. 2012. Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics. PLoS One. 7:e35768.
- Zheng H, Jiang C, Chiu MH, Covey JM, Chan KK. 2002. Chiral pharmacokinetics and inversion of enantiomers of a new quinoxaline topoisomerase IIbeta poison in the rat. Drug Metab Dispos. 30:344–348.
- Zhou Q, Yu LS, Zeng S. 2014. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction. Drug Metab Rev. 46:283–290.